ELI Lilly has received confirmation from Limerick City and County Council that all required planning processes are complete and the company has permission to proceed with the development of its new biopharmaceutical campus at Raheen.
The company has begun to mobilise an initial project team at the site in Raheen to commence preparatory works such as implementation of health and safety requirements in advance of site clearance activities.
The Lilly site at Raheen will become an active construction site with immediate effect and initial steps will be taken this week to close the site to members of the public in line with construction safety legislation.
In a statement issued this evening (Monday), Lilly said it recognised that the site has been used as an unofficial recreation area for several years and understand that the closure of the site may be a disappointment to some but is required for the safety of all.
“We will work with the local community to identify opportunities to support other existing amenities in the area where possible,” the statement added.
The initial construction phase of the project will see over 500 people employed on the site and this number is likely to increase in coming months as the project activity ramps up.
A 2½ year timeline has been set for completion of construction with more than 300 new highly skilled jobs for engineers, scientists, and operations technicians. Many other professionals with supply chain, finance and human resources expertise will also be employed.
The new facility will expand Lilly’s global manufacturing network for biologic active ingredients and support increased demand for existing Lilly products.
